Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New care model aims to save mothers and babies with sickle cell disease

NCT ID NCT05143021

Disease control Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special care program for pregnant women with sickle cell disease in Ghana. A team of obstetric and sickle cell experts works together to prevent complications and reduce deaths. Researchers will track 500 women to see if this low-cost approach improves survival and health for both mothers and babies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multidisciplinary care program (obstetrics and sickle cell disease teams)
What this could lead to
If successful, this could provide a low-cost model to reduce maternal and infant deaths in sickle cell disease pregnancies.
What could go wrong
This is an observational study without a control group, so improvements may be due to other factors. Results may not apply outside Ghana.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2022

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women and their health care providers living with SCD in Ghana (Accra-Tema metropolis and Tamale).

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All study participants will be adults between the reproductive ages of 18 to 45 years as defined by World Health Organization (WHO) * Confirmed SCD status by Hb-electrophoresis in alkaline medium * Pregnancy should be confirmed by urine or blood pregnancy test and pelvic ultrasound scan. Exclusion Criteria: * All pregnant women without a confirmed Hb phenotype or electrophoresis report * All pregnant women with SCD who present to the Greater Accra Regional Hospital or Tamale Teaching Hospital for acute admissions, labor, and delivery * All pregnant women with SCD with undetermined Hb phenotypes on Hb electrophoresis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy related are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pregnancy disorder sickle cell disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pregnancy related Sickle cell disease

Contacts and locations

Locations

  • Greater Accra Regional Hospital

    Accra, Ghana

  • Korle Bu Teaching Hospital

    Accra, Ghana

  • Tamale Teaching Hospital

    Tamale, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.